This Week at FDA: FDA eases digital health oversight, MDUFA negotiation update, and more

This Week at FDAThis Week at FDABiologics/ biosimilars/ vaccinesDiagnostics/IVDsGovernment/legislationGuidanceLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)